Keyword Suggestion
Domain Informations
Cerevasc.com lookup results from whois.godaddy.com server:
- Domain created: 2014-03-19T00:45:39Z
- Domain updated: 2024-02-18T14:00:58Z
- Domain expires: 2032-03-19T00:45:39Z 7 Years, 294 Days left
- Website age: 10 Years, 71 Days
- Registrar Domain ID: 1851044561_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS31.DOMAINCONTROL.COM
- NS32.DOMAINCONTROL.COM
Network
- inetnum : 130.211.0.0 - 130.211.255.255
- name : GOOGLE-CLOUD
- handle : NET-130-211-0-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : ** The IP addresses under this netblock are in use by Google Cloud customers **,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.,*** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 130.211.171.61
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 130.211.171.61)
Spam Check (IP: 130.211.171.61)
Email address with cerevasc.com
Recent Searched Sites
› Ticketjam.jp (3 seconds ago) / JP
› Lgcclinicaldiagnostics.com (34 seconds ago) / US
› Guide.libreassociation.info (41 seconds ago) / DE
› Mbabm.uz (16 seconds ago) / UA
› Cerevasc.com (1 seconds ago) / US
› Bloggersforthekingdom.com (4 seconds ago) / US
› Kauffman.org (5 seconds ago) / US
› Haodiy.net (28 seconds ago) / CN
› Blog.interviewing.io (11 seconds ago) / US
› Ramld.ru (8 seconds ago) / RU
› Douglasjacoby.com (19 seconds ago) / US
› Tlaxcala.gob.mx (58 seconds ago) / MX
› Avanzapormas.com (19 seconds ago) / AR
› Tomassa.com.ar (15 seconds ago) / FI
› Thinkaboutsuchthings.com (36 seconds ago) / US
› Seoulmetrocoop.co.kr (32 seconds ago) / KR
› Life.nib.com.au (5 seconds ago) / US
› 9sod.com (4 seconds ago) / US
› Madisonva.com (14 seconds ago) / US
› Jeremiah-moze.vids.io (44 seconds ago) / US
Websites Listing
We found Websites Listing below when search with cerevasc.com on Search Engine
eShunt™ Device | Contact CereVasc
EShunt™ Device | Contact CereVasc Admin 2021-04-01T20:43:08+00:00. Contact CereVasc. Please provide us with your contact information so that we may send you information about CereVasc, Inc. and the eShunt TM System that is currently under development. Name* * Your Email * Please leave this field empty. Subject* Message* Please leave this field empty. ×. …
Cerevasc.comeShunt™ Device Endovascular Shunt | CereVasc Team
Daniel Levangie is an experienced executive with senior operating experience in the field of medical devices and in vitro diagnostics. Mr. Levangie is currently the Chairman and Chief Executive Officer of Cerevasc, Inc. and co-founder and Managing Partner of ATON Partners, LLC, a Boston based private investment and management consulting firm.. Most recently, Mr. …
Cerevasc.comCereVasc - Crunchbase Company Profile & Funding
1 email found . View contacts for CereVasc to access new leads and connect with decision-makers. View All Contacts . Details. Industries . Biotechnology. Health Care. Medical Device . Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date Jan 1, 2014; Founders Adel Malek, Carl Heilman, Daniel Levangie, Patrick Sullivan; Operating Status …
Crunchbase.comTufts Medical Center and ATON Partners Announce ... - …
2014-08-06 · Initially CereVasc, LLC will develop a novel technology designed by the neurosurgical team at Tufts Medical Center to dramatically improve the process and lower the cost of treatment of communicating hydrocephalus. Communicating hydrocephalus affects more than 300,000 patients in the United States and represents a $1 billion annual medical cost in …
Cerevasc.comCereVasc
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. CereVasc's ultimate goal is to transform the common procedure into an outpatient, one-day surgery alternative. CereVasc was co-founded in 2014 by Dan Levangie, Patrick Sulivan, Carl Heilman and Adel Malek. The company is …
Paganresearch.ioHome - Cerevance
A Pipeline of Discovery and Clinical Stage Compounds. Cerevance is developing therapeutics that act on target proteins expressed highly selectively in brain cell types that die in disease, play a key role in the disease process, or are located in brain circuits disrupted by disease. In some cases, our NETSseq platform has revealed that a target ...
Cerevance.comCereVasc Announces Closing of $43.9 Million Series A ...
2020-06-09 · CereVasc Contact: Dan Levangie Chief Executive Officer CereVasc, Inc. [email protected] Media Contact: Emmie Twombly LaVoieHealthScience [email protected] 857-389-6042 Site Navigation
Businesswire.comCereVasc Announces Closing of $43.9 Million Series A ...
2020-06-09 · Press Release CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, announced today the closing of an expanded Series A financing that raised a total of $43 ...
Venturebeat.comCereVasc LLC Management | CereVasc LLC Management Team
Before RocketReach, the process of sourcing email addresses consisted of scouring the internet, asking mutual friends, or stalking on LinkedIn. The most frustrating part was how time consuming this all was.The first time I used RocketReach was when I realized I made the right decision. Finding emails for contacts turned into a one-and-done instead of a week long process.
Rocketreach.coMark Licari - Vice President, Operations - CereVasc ...
View Mark Licari's business profile as Vice President, Operations at CereVasc. Find contact's direct phone number, email address, work history, and more.
Zoominfo.comCereVasc
2020-06-10 · CereVasc. By Ashlyn Roberts • 10 Jun, 2020 • June 10, 2020 CereVasc, a Boston-based biotech focused on hydrocephalus, raised $44 million in Series A funding co-led by ATON Partners and Perceptive Advisors. ← Older Post. Newer Post → Share. Tweet. Share. Mail. Werewolf Therapeutics. By Ashlyn Roberts • 30 Apr, 2021 • April 30, 2021 Werewolf …
Incubatecoalition.orgCereVasc Receives FDA IDE Approval to Begin Initial ...
2022-02-08 · CereVasc, Inc. [email protected] SOURCE CereVasc, Inc. × Modal title. Also from this source. CereVasc Announces Publication of First-in-Human Case Report of... Explore. More news releases in ...
Prnewswire.comCereVasc Announces Publication of First-in-Human Case ...
2021-12-07 · Surrounding Massachusetts' healthcare hub, CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development of novel, minimally invasive treatments for ...
Prnewswire.comCereVasc LLC Information | CereVasc LLC Profile
CereVasc, Inc. is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. The Company's first product, the eShunt System, is the first minimally invasive, endovascular, cerebrospinal fluid shunt and delivery componentry designed to avoid the need for invasive surgery and extended …
Rocketreach.coCereVasc Receives FDA IDE Approval to Begin Initial ...
2022-02-08 · About CereVasc, Inc. Located in Massachusetts' healthcare hub, CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. It's flagship product, the eShunt System, is intended to offer the first minimally invasive treatment for communicating …
Biospace.comCereVasc’s eShunt Device Evaluated in FIH Trial for ...
2021-12-07 · December 7, 2021—CereVasc, Inc. announced the publication of a case report detailing the first-in-human (FIH) treatment in a study of the company’s eShunt system, an investigational device intended to treat communicating hydrocephalus (CH).
Evtoday.comCereVasc nets $43M to test minimally invasive ...
2020-06-09 · CereVasc nets $43M to test minimally invasive hydrocephalus procedure. CereVasc's ultimate goal is to transform the common procedure into an outpatient, one-day surgery alternative. (Ildar Imashev ...
Fiercebiotech.comCereVasc Announces Publication of First-in-Human Case ...
2021-12-07 · About CereVasc, Inc. Surrounding Massachusetts' healthcare hub, CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. It's flagship product, the eShunt™ System, is intended to offer the first minimally invasive treatment for communicating …
Biospace.comCereVasc nets $43M to test minimally invasive ...
2020-06-10 · CereVasc estimates that about half of the 130,000 shunt-placement procedures performed each year in the U.S. and Western Europe are revision procedures for failed devices. The company’s ultimate goal is to transform the procedure into an outpatient, one-day surgery alternative. The eShunt also aims to address the catheter obstructions, infections and the over …
Biotech-insider.comCerevasc, LLC Company Profile | Auburndale, MA ...
Find company research, competitor information, contact details & financial data for Cerevasc, LLC of Auburndale, MA. Get the latest business insights from Dun & Bradstreet.
Dnb.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| eduxfactor.com | godaddy.com | -1 Years, -332 Days |
| javtxt.net | cloudflare.com | -2 Years, -2 Days |
| jenolite.com | godaddy.com | 1 Year, 98 Days |
| eclypsium.com | domains.google.com | 1 Year, 160 Days |
| superbuzz.io | godaddy.com | -2 Years, -26 Days |
| bankgid.com | reg.ru | -1 Years, -345 Days |
| bettersystemtrader.com | namecheap.com | -1 Years, -151 Days |
| godasresearch.com | cdmon.com | -1 Years, -207 Days |
| drmisch.com | namecheap.com | -1 Years, -160 Days |
| maciag-offroad.com | registrygate.com | -1 Years, -274 Days |